SECURITY & EXCHANGE 8-K/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported):  July 31, 2003

CROMPTON CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

0-30270

52-2183153

(State or other jurisdiction of
incorporation or organization)

(Commission File Number)

(I.R.S. Employer
Identification Number)

 

 

 


199 Benson Road,Middlebury, Connecticut



06749

(Address of principal executive offices)

 

(Zip Code)

 

 

 

(203)573- 2000
(Registrant's telephone number,
including area code)

 

 

 

 

ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.

On July 31, 2003, Crompton Corporation announced that it completed the sale of its Organosilicones Business to General Electric Company and acquired the GE Specialty Chemicals business in a transaction valued at as much as $1.05 billion. This Form 8-K/A amends the Registrant’s Report on Form 8-K filed on July 31, 2003 to provide pro forma financial information as required by Article 11 of Regulation S-X in connection with the transaction described in the original Form 8-K. Pro forma financial information pertaining to this transaction is set forth in Item 7 below.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

(a) Financial statements of businesses acquired.

Not applicable.

(b) Unaudited Pro Forma Combined Financial Information

The following unaudited pro forma combined financial information gives effect to the sale of the OrganoSilicones Business (OSI) and the acquisition of the Specialty Chemicals Business (GESC) from General Electric Company (GE), together referred to as "the transaction". The information is based upon the historical financial statements of Crompton Corporation (Crompton) and GESC. The information should be read in conjunction with Crompton’s historical financial statements, the related notes, and other information contained elsewhere or incorporated by reference in this Form 8-K/A. Certain items derived from Crompton’s and GESC’s historical financial statements have been reclassified to conform to the combined presentation.

The unaudited pro forma combined financial information is not necessarily indicative of what the actual combined financial position or results of operations would have been had the foregoing transaction been consummated on the dates set forth therein, nor does it give effect to (i) any transaction other than the sale of OSI and acquisition of GESC, (ii) Crompton’s or GESC’s results of operations since June 30, 2003, (iii) any synergies, cost savings, and one-time charges or credits expected to result from the sale of OSI and the acquisition of GESC or (iv) the results of final valuations of GESC assets acquired and liabilities assumed. We are currently in the process of integrating the GESC operations, which may involve various costs including severance and other charges, which may be material. We may also revise the allocation of the purchase price of the GESC business when additional information becomes available. Accordingly, the pro forma combined financial information does not purport to be indicative of the financial position or results of operations as of the date hereof, as of the effective date of the transaction, or for any other future date or period.

(c) Exhibits.

Number

Description

2.1 Purchase and Exchange Agreement by and between Crompton Corporation and General Electric Company, dated as of April 24, 2003 (incorporated by reference to Exhibit 99.2 to the Registrant’s Form 8-K dated April 25, 2003).
   

 

 

 

 

 

2

 

 

UNAUDITED PRO FORMA COMBINED BALANCE SHEET
AS OF JUNE 30, 2003
(In thousands of dollars)

 

     

CROMPTON

   

OSI
NET ASSETS SOLD

     

PROCEEDS AND GESC NET ASSETS ACQUIRED

   

PRO FORMA ADJUSTMENTS

     

PRO FORMA COMBINED

 

ASSETS

                                   

CURRENT ASSETS

Cash

$

18,366

$

-

$

643,115

(1)

$

(643,115

)

(1)

$

18,366

Accounts receivable

   

192,293

   

-

     

16,705

(2)

 

31,585

 

(1)

 

240,583

 

Inventories

   

382,569

   

-

     

25,425

(2)

 

-

     

407,994

 

Other current assets

   

91,755

   

-

     

25,741

(3)

 

-

     

117,496

 

Assets held for sale

   

383,097

   

(383,097

)

   

-

   

-

     

-

 

                                   

   Total current assets

   

1,068,080

   

(383,097

)

   

710,986

   

(611,530

)

   

784,439

 
                                   

NON-CURRENT ASSETS

                                   

Property, plant and equipment

   

705,158

   

-

     

71,066

(2)

 

(3,301

)

(4)

 

772,923

 

Cost in excess of acquired

                                   

   net assets

   

586,115

   

-

     

60,674

(2)

 

(213,980

)

(4)

 

432,809

 

Other assets

   

500,701

   

-

     

73,884

(3)

 

(895

)

(4)

     
                 

636

(2)

 

(151,547

)

(5)

     
                       

(8,306

)

(6)

 

414,473

 

                                   
 

$

2,860,054

 

$

(383,097

)

 

$

917,246

 

$

(989,559

)

 

$

2,404,644

 

                                   

LIABILITIES AND STOCKHOLDERS’ EQUITY

                                   

CURRENT LIABILITIES

                                   

Notes payable

 

$

9,684

 

$

-

   

$

-

 

$

-

   

$

9,684

 

Accounts payable

   

253,708

   

-

     

9,304

(2)

 

28,057

 

(7)

 

291,069

 

Accrued expenses

   

234,939

   

-

     

5,202

(2)

 

31,366

 

(8)

 

271,507

 

Income taxes payable

   

83,446

   

-

     

-

   

10,000

 

(5)

 

93,446

 

Other current liabilities

   

15,156

   

-

     

-

   

-

     

15,156

 

Liabilities held for sale

   

28,181

   

(28,181

)

   

-

   

-

     

-

 

                                   

Total current liabilities

   

625,114

   

(28,181

)

   

14,506

   

69,423

     

680,862

 
                                   

NON-CURRENT LIABILITIES

                                   

Long-term debt

   

1,286,709

   

-

     

-

   

(512,726

)

(1)

 

773,983

 

Post-retirement health care
    liability

   

192,004

   

-

     

-

   

-

     

192,004

 

Other liabilities

   

501,397

   

-

     

-

   

(75,000

)

(1)

     
                       

(411

)

(4)

 

425,986

 
                                   

STOCKHOLDERS’ EQUITY

                                   

Common stock

   

1,192

   

-

     

-

   

-

     

1,192

 

Additional paid-in capital

   

1,045,094

   

-

     

-

   

-

     

1,045,094

 

Accumulated deficit

   

(601,252

)

 

(354,916

)

(9)

 

902,740

(9)

 

(444,888

)

(9)

     
                       

(14,520

)

(10)

 

(512,836

)

Accumulated other    
   comprehensive loss
   

(111,820

)

 

-

     

-

   

(11,437

)

(11)

 

(123,257

)

Treasury stock at cost

   

(78,384

)

 

-

     

-

   

-

     

(78,384

)

                                   

Total stockholders’ equity

   

254,830

   

(354,916

)

   

902,740

   

(470,845

)

   

331,809

 

                                   
 

$

2,860,054

 

$

(383,097

)

 

$

917,246

 

$

(989,559

)

 

$

2,404,644

 

                                   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2003
(In thousands of dollars, except per share data)

 

         

CROMPTON CONTINUING OPERATIONS

     

GESC

     

PRO FORMA ADJUSTMENTS

       

PRO FORMA COMBINED

 

 

                                     

Net sales

$

1,064,873

$

78,683

$

1,884

(12)

$

1,145,440

                                       

Cost of products sold

       

779,595

     

60,119

(14)

   

(794

)

(12)

       
                         

(376

)

(13)

   
838,544
 

Selling, general and administrative

       

172,100

     

8,599

     

1,063

 

(12)

       
                         

(2,560

)

(13)

   

179,202

 

Depreciation and amortization

       

54,498

     

5,009

     

-

       

59,507

 

Research and development

       

24,786

     

694

     

-

       

25,480

 

Equity (income) loss

       

(7,842

)

   

-

     

-

       

(7,842

)

Facility closures, severance
  and related costs

       

3,505

     

-

     

-

       

3,505

 

Antitrust legal costs

       

20,875

     

-

     

-

       

20,875

 

                                       

Operating profit

       

17,356

     

4,262

     

4,551

       

26,169

 

Interest expense

       

52,274

     

-

     

(13,230

)

(15)

   

39,044

 

Other expenses, net

       

4,040

     

(810

)

   

1,615

 

(12)

       
                         

(626

)

(13)

       
                         

(1,664

)

(16)

       
                         

(527

)

(17)

   

2,028

 

Earnings (loss) from continuing
   operations before income taxes

       

(38,958

)

   

5,072

     

18,983

       

(14,903

)

Income taxes (benefit)

       

(12,838

)

   

1,866

     

7,403

 

(18)

   

(3,569

)

Earnings (loss) from continuing
   operations

     

$

(26,120

)

 

$

3,206

   

$

11,580

     

$

(11,334

)

Basic and Diluted earnings
   (loss) per common share:

Earnings (loss) from
   continuing operations

     

$

(0.23

)

                   

$

(.10

)

                                       
                                       

Basic and Diluted weighted
   average shares outstanding

       

113,389

                       

113,389

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 


UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2002

(In thousands of dollars, except per share data)

   

CROMPTON

   

OSI

   

CROMPTON
CONTINUING
OPERATIONS

     

GESC

       

PRO FORMA
ADJUSTMENTS

         

 PRO FORMA
  COMBINED

 

 

                                               

Net sales

$

2,546,872

$

(456,601

)

$

2,090,271

$

165,968

$

2,980

(12)

$

2,259,219

                                                 

Cost of products sold

1,754,123

(284,244

)

1,469,879

120,030

(14)

(1,237

)

(12)

                                 

(751

)

 

(13)

   
1,587,921
 
                                             

 

 
                                                 
Selling, general and                                                

   administrative

 

396,266

   

(40,877

)

 

355,389

     

17,154

       

1,777

   

(12)

       
                                 

(5,121

)

 

(13)

   

369,199

 

Depreciation and

                                               

   amortization

 

146,550

   

(35,124

)

 

111,426

     

10,158

       

-

         

121,584

 

Research and development

 

81,872

   

(27,587

)

 

54,285

     

692

       

-

         

54,977

 

Equity (income) loss

 

(7,917

)

 

-

   

(7,917

)

   

-

       

-

         

(7,917

)

Facility closures, severance

                                               

   and related costs

 

23,317

   

(5,348

)

 

17,969

     

-

       

-

         

17,969

 

Antitrust legal costs

 

6,306

   

-

   

6,306

     

-

       

-

         

6,306

 

                                                 

Operating profit

 

146,355

   

(63,421

)

 

82,934

     

17,934

       

8,312

         

109,180

 

Interest expense

 

101,704

   

-

   

101,704

     

-

       

(31,533

)

 

(15)

   

70,171

 

Other expense, net

 

35,366

   

212

   

35,578

     

(565

)

     

2,440

   

(12)

       
                                 

(1,253

)

 

(13)

       
                                 

(2,974

)

 

(16)

       
                                 

(1,472

)

 

(17)

   

31,754

 
                                                 

Earnings (loss) before

                                               

   income taxes

 

9,285

   

(63,633

)

 

(54,348

)

   

18,499

       

43,104

         

7,255

 

Income taxes (benefit)

 

(6,189

)

 

(12,714

)

 

(18,903

)

   

6,923

       

16,811

   

(18)

   

4,831

 

                                                 

Earnings (loss) from

                                               

   operations

$

15,474

 

$

(50,919

)

$

(35,445

)

 

$

11,576

     

$

26,293

       

$

2,424

 

                                                 
Basic earnings (loss)
    per common share:
                                               

                                               

Earnings (loss) from
    continuing operations

           

$

(.31

)

                       

$

0.02

 

                                                 

Diluted earnings (loss)
   per common share:

Earnings (loss) from continuing  operations

$

(.31

)

$

0.02

                                                 
                                                 

Basic weighted average

                                               

   shares outstanding

             
113,568
                           
113,568
 

Diluted weighted average
   shares outstanding

113,568

115,656

 

 

 

5

NOTES TO UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION

(1) Reflects the cash proceeds on the transaction which were used to repay $250 million of Crompton’s 8.5% long-term notes and $262.7 million of other long-term debt outstanding, pay premiums of $23.8 million relating to the early extinguishment of the 8.5% notes, fund the outstanding accounts receivable securitization related to OSI of $31.6 million and contribute $75 million to certain Crompton pension plans.

(2) Reflects GESC assets acquired and liabilities assumed.

(3) Reflects the present value of the minimum contingent quarterly payments of $105 million to be received from GE over the three-year period following the close of the transaction. An additional $145 million can be earned based on the combined performance of GE’s existing silicones business and the OSI business acquired by GE, but this amount has not been reflected in the pro forma combined financial statements.

(4) Reflects an adjustment to write-off the goodwill associated with OSI and certain other OSI related assets and liabilities which were not sold in the transaction.

(5) Reflects the estimated current and deferred income tax effect on the gain on the transaction, on the premium relating to the early extinguishment of debt and on the $75 million contribution to certain Crompton pension plans. Such amounts are based on the applicable statutory tax rates.

(6) Reflects the write-off of deferred transaction costs.

(7) Reflects the excess of retained accounts receivable over retained accounts payable attributable to OSI that is payable to GE.

(8) Reflects an adjustment to accrue for expenses associated with the transaction, including investment banking, legal, audit, consulting fees and other costs.

(9) Reflects the pro forma gain of $102.9 million recorded on the transaction, net of tax, based on assets and liabilities held for sale as of 6/30/03.

(10) Reflects the impact of the premium paid on the early extinguishment of debt of $23.8 million, net of taxes of $9.3 million recorded at the applicable statutory tax rate.

(11) Reflects the write-off of the cumulative translation adjustment associated with certain foreign locations exclusively or predominantly engaged in the OSI business.

(12) Reflects certain reclassifications made to conform to Crompton’s presentation.

(13) Reflects adjustments to pension expense due to the assumed contribution of $75 million of the proceeds from the transaction to certain Crompton pension plans.

6

(14) The pro forma combined statements of operations do not reflect adjustments to cost of products sold for purchases of certain products purchased by GESC from an affiliate at less than market price. In accordance with the transaction contract, Crompton will purchase such products at substantially market price, which will result in an annual increase to cost of products sold of approximately $5 million.

(15) The reduction in interest expense for the pro forma periods ending June 30, 2003 and December 31, 2002 are based on the assumed use of proceeds as of January 1, 2003 and January 1, 2002, respectively. These assumptions vary from the actual use of proceeds subsequent to the transaction and from the assumed use of proceeds reflected on the Unaudited Pro Forma Combined Balance Sheet as of June 30, 2003 as noted in Note (1) above. The outstanding debt balances assumed to be reduced with the proceeds from the transaction and the assumed residual cash balances are shown in the table below. The table also shows the related interest expense savings associated with the debt reductions based on the applicable interest rates.

 

   

Assumed Use of Proceeds at 6/30/03

 

Assumed Use of Proceeds at 1/1/03

   

6/30/03
Interest Expense Reduction Assuming
1/1/03 Use
of Proceeds

 

Assumed
Use of Proceeds
at 1/1/02

   

12/31/02
Interest Expense Reduction Assuming
1/1/02 Use
of Proceeds

 

8.5% notes

$

250,000

$

250,000

$     10,625

$

250,000

$     21,250

 

Premium of 8.5%
   notes

23,804

23,804

-

23,804

-

Domestic credit
    Facility

201,411

25,000

445

155,000

5,937

Other long-term
   debt

 

61,315

 

57,051

 

2,160

 

72,828

 

4,346

 
 

Pension
   Contribution

 

75,000

 

75,000

 

-

 

75,000

 

-

 

A/R securitization funding

 

31,585

 

40,333

 

-

 

34,424

 

-

 

Cash

 

-

 

171,927

 

-

 

32,059

 

-

 

 

$

643,115

$

643,115

$      13,230

$

643,115

$     31,533

 

                       

 

No pro forma interest income has been reflected on the residual cash. If the residual cash had been reflected as a reduction in revolver borrowings over the six month period ended June 30, 2003 and the year ended December 31, 2002, a further reduction of interest expense of $3.1 million and $1.2 million, respectively, would have resulted.

(16) Reflects the accretion of the receivable due from GE noted in Note (3) to its face value.

(17) Reflects a reduction of fees attributable to the outstanding accounts receivable securitization program related to OSI that was assumed to be repaid with the proceeds from the transaction as noted in Note (1).

(18) Reflects the income tax effect of the pro forma adjustments based on the applicable statutory tax rate.

 

 

 

 

7

 

SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.

       

       

   

Crompton Corporation

 

       

(Registrant)

      

By: /s/ Barry J. Shainman

Name: Barry J. Shainman
Title: Secretary

Date: October 14, 2003

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8

 

Exhibit Index  
Exhibit Number Exhibit Description
2.1 Purchase and Exchange Agreement by and between Crompton Corporation and General Electric Company, dated as of April 24, 2003 (incorporated by reference to Exhibit 99.2 to the Registrant’s Form 8-K dated April 25, 2003).
   

 

 

 

 

 

 

 

 

 

 

 

        9